JP2024527593A5 - - Google Patents
Info
- Publication number
- JP2024527593A5 JP2024527593A5 JP2024501098A JP2024501098A JP2024527593A5 JP 2024527593 A5 JP2024527593 A5 JP 2024527593A5 JP 2024501098 A JP2024501098 A JP 2024501098A JP 2024501098 A JP2024501098 A JP 2024501098A JP 2024527593 A5 JP2024527593 A5 JP 2024527593A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- modified immune
- polypeptide
- immune cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/105484 | 2021-07-09 | ||
| CN2021105481 | 2021-07-09 | ||
| CN2021105484 | 2021-07-09 | ||
| CNPCT/CN2021/105481 | 2021-07-09 | ||
| PCT/CN2022/104638 WO2023280307A1 (en) | 2021-07-09 | 2022-07-08 | Mutant il-15 compositions and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527593A JP2024527593A (ja) | 2024-07-25 |
| JP2024527593A5 true JP2024527593A5 (https=) | 2025-06-20 |
Family
ID=84801325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501098A Pending JP2024527593A (ja) | 2021-07-09 | 2022-07-08 | 変異型ｉｌ－１５組成物及びその方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240209050A1 (https=) |
| EP (1) | EP4367223A4 (https=) |
| JP (1) | JP2024527593A (https=) |
| KR (1) | KR20240055714A (https=) |
| CN (1) | CN117616116A (https=) |
| AU (1) | AU2022307402A1 (https=) |
| WO (1) | WO2023280307A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
| WO2024218688A1 (en) * | 2023-04-18 | 2024-10-24 | Board Of Regents, The University Of Texas System | Bcma chimeric antigen receptors and uses thereof |
| WO2025179221A1 (en) * | 2024-02-22 | 2025-08-28 | Senti Biosciences, Inc. | Compositions and methods for armored cell based therapies |
| CN118406654B (zh) * | 2024-04-26 | 2025-03-21 | 中国海洋大学 | 经修饰的nk细胞及其构建方法和应用 |
| WO2026037415A1 (zh) * | 2024-08-16 | 2026-02-19 | 北京清辉联诺生物科技有限责任公司 | 一种IL15/IL15Rα复合物及其在细胞疗法领域的应用 |
| WO2026077446A1 (en) * | 2024-10-12 | 2026-04-16 | Nanjing Legend Biotech Co., Ltd. | Engineered il-15 constructs and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3783098A1 (en) * | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| EP3347026A4 (en) * | 2015-09-09 | 2019-05-08 | Seattle Children's Hospital (DBA Seattle Children's Research Institute) | GENEMANIPULATION OF MACROPHAGES FOR IMMUNOTHERAPY |
| US11866731B2 (en) * | 2017-11-10 | 2024-01-09 | Chineo Medical Technology Co., Ltd | Modified immune cells and uses thereof |
| CN112004547A (zh) * | 2018-02-26 | 2020-11-27 | 新索思股份有限公司 | Il-15缀合物及其用途 |
| CA3141626A1 (en) * | 2019-06-12 | 2020-12-17 | AskGene Pharma, Inc. | Novel il-15 prodrugs and methods of use thereof |
| JP7807076B2 (ja) * | 2019-12-13 | 2026-01-27 | キュージーン インコーポレイテッド | 新規インターロイキン－１５（ｉｌ－１５）融合タンパク質およびその使用 |
-
2022
- 2022-07-08 JP JP2024501098A patent/JP2024527593A/ja active Pending
- 2022-07-08 WO PCT/CN2022/104638 patent/WO2023280307A1/en not_active Ceased
- 2022-07-08 CN CN202280047519.8A patent/CN117616116A/zh active Pending
- 2022-07-08 AU AU2022307402A patent/AU2022307402A1/en active Pending
- 2022-07-08 US US18/576,630 patent/US20240209050A1/en active Pending
- 2022-07-08 KR KR1020247001047A patent/KR20240055714A/ko active Pending
- 2022-07-08 EP EP22837052.4A patent/EP4367223A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527593A5 (https=) | ||
| JP7488854B2 (ja) | ヘテロダイマーＦｃ融合サイトカインおよびそれを含む医薬組成物 | |
| ES2916092T3 (es) | Nuevos receptores de linfocitos T e inmunoterapias basadas en el uso de los mismos | |
| JP2022130427A (ja) | 改変されたインターロイキン－７タンパク質およびその使用 | |
| JP6783797B2 (ja) | 抗がん融合ポリペプチド | |
| US9206243B2 (en) | IL-2 derivative polypeptides | |
| CN104507963B (zh) | 鼠抗‑ny‑eso‑1 t细胞受体 | |
| AU2009282886B2 (en) | RCC Tcell receptors and related materials and methods of use | |
| JP2022109953A5 (https=) | ||
| US7112436B1 (en) | Conjugate for modifying interactions between proteins | |
| BR112020023167A2 (pt) | polipeptídeos de citocina ativáveis e métodos de uso destes | |
| TW202206453A (zh) | 表現嵌合抗原受體之病毒特異性免疫細胞 | |
| JP2018519803A (ja) | 抗がん性融合ポリペプチド | |
| AU2016336817A1 (en) | High avidity HPV T-cell receptors | |
| WO2016071343A1 (en) | T cell receptors | |
| JP2020536552A5 (https=) | ||
| CN114729026B (zh) | 用于稳定免疫突触的嵌合抗原受体（car）t细胞 | |
| JP2024504728A5 (https=) | ||
| JP2019530441A5 (https=) | ||
| CN114746106A (zh) | 通过肿瘤中使用il-7融合蛋白增加淋巴细胞数的方法 | |
| JP2022526194A (ja) | Ｆｌｔ３特異的キメラ抗原受容体およびその使用方法 | |
| ES2240475T3 (es) | Peptidos terapeuticos. | |
| TW202309074A (zh) | 包含含有il-2蛋白及cd80蛋白之融合蛋白與自然殺手細胞的用於治療癌症的藥學組成物 | |
| CN116194574A (zh) | 嵌合抗原受体细胞 | |
| RU2832136C1 (ru) | Композиция для противоракового лечения, содержащая nk-клетки и слитый белок, который содержит белок il-2 и белок cd80 |